Showing results (221-230 of 239) with videos related to
Sort By:
Pageof 24
Cell|April 18, 2020
Roadmap for the Emerging Field of Cancer NeuroscienceMichelle Monje, Jeremy C Borniger, Nisha J D'Silva, et al.Nature Reviews. Cancer|January 26, 2020
A framework for advancing our understanding of cancer-associated fibroblastsErik Sahai, Igor Astsaturov, Edna Cukierman, et al.Cell|September 27, 2014
Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapyMara H Sherman, Ruth T Yu, Dannielle D Engle, et al.Cancer Discovery|May 5, 2019
Oral Mucosal Organoids as a Potential Platform for Personalized Cancer TherapyElse Driehuis, Sigrid Kolders, Sacha Spelier, et al.The Journal of Experimental Medicine|May 23, 2020
SIRT1-NOX4 signaling axis regulates cancer cachexiaAneesha Dasgupta, Surendra K Shukla, Enza Vernucci, et al.Cancer Research|December 6, 2006
Demonstration of a genetic therapeutic index for tumors expressing oncogenic BRAF by the kinase inhibitor SB-590885Alastair J King, Denis R Patrick, Roberta S Batorsky, et al.Gut|February 11, 2022
Oral famotidine versus placebo in non-hospitalised patients with COVID-19: a randomised, double-blind, data-intense, phase 2 clinical trialChristina M Brennan, Sandeep Nadella, Xiang Zhao, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2025
PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic CancerJennifer J Knox, Grainne O'Kane, Daniel King, et al.Science (New York, N.Y.)|May 23, 2009
Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancerKenneth P Olive, Michael A Jacobetz, Christian J Davidson, et al.Nature|June 16, 2012
The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinomaPedro A Pérez-Mancera, Alistair G Rust, Louise van der Weyden, et al.Pageof 24